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Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis
species: Case report and review of the literature
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William H. Pentz, MD,d and Charles R. Bridges, MD, ScD,a Philadelphia, Pa
Scopulariopsis species is a keratinolytic mold with apropensity to cause onychomycosis and rarely to causedeep tissue infection. Scopulariopsis brevicaulis is themost common Scopulariopsis species seen clinically. We
review 3 cases of Scopulariopsis species–induced endocarditis in
the literature and present a fourth case of Scopulariopsis species–
induced prosthetic valve endocarditis.
Clinical Summary
A 67-year-old woman with a past medical history signiﬁcant for
rheumatic fever, gout, pulmonary hypertension, atrial ﬁbrillation,
congestive heart failure, and 3 prior valve operations presented
with fever and right leg pain. One year before presentation she
underwent replacement of her aortic and mitral valves with a
19-mm Carpentier-Edwards Magna pericardial valve and a 25-mm
Carpentier-Edwards pericardial valve (Baxter Healthcare Corp,
Edwards Lifesciences, Irvine, Calif), respectively. Her social his-
tory was signiﬁcant for pet ﬁnches. Her temperature was 101°F,
she had a systolic murmur at the left sternal border, and her right
foot was cold with diminished pulses. She had no evidence of
onychomycosis or peripheral emboli. Abdominal computed to-
mography demonstrated a nonocclusive clot in the right ileac
artery. Hematologic parameters and chemistries were normal.
Blood cultures, including fungal isolator blood cultures incubated
over 4 weeks, were negative. After the patient’s left leg became
cold and pulseless, she urgently underwent thromboendarterec-
tomy of an acutely occluded femoral artery. Pathology from the
embolectomized specimen demonstrated septated hyphal elements.
Subsequently on day 5, fungal cultures grew a mold morpholog-
ically identiﬁed as a Scopulariopsis species (Figure 1). She under-
went a transesophageal echocardiogram revealing a larger than
12-mm vegetation on the mitral valve with moderate mitral regur-
gitation. Conﬁrmatory identiﬁcation and susceptibility testing
performed at Focus Diagnostics (Cyprus, Calif) identiﬁed the
organism as S brevicaulis and demonstrated mean inhibitory
concentrations of 4 g/mL to amphotericin B, 1 g/mL to terbi-
naﬁne, 8 g/mL to voriconazole, and greater than 8 g/mL to
itraconazole. The patient underwent excision of the senescent
infected mitral valve pericardial prosthesis, extensive debridement
of the associated fungal vegetation, and a mitral valve replacement
with a Carpentier-Edwards pericardial valve. She was treated
preoperatively and postoperatively with amphotericin B and vori-
conazole. The amphotericin was continued for 3 weeks postoper-
atively, and the voriconazole was arbitrarily continued for 11
weeks until the patient could not tolerate it because of debilitating
nausea. She had a complicated respiratory course postoperatively
and was discharged to a rehabilitation facility. She was subse-
quently readmitted with dyspnea and died 5 months after initial
presentation without signs of recurrent infection. Culture of her pet
ﬁnch’s feathers grew Aspergillus species and not Scopulariopsis
species, despite the mold’s propensity to grow in bird feathers.
Discussion
Fungi are responsible for less than 10% of cases of infective
endocarditis. Although the majority of these are caused by
Candida species, infections with opportunistic mold are seen in
patients with previous valve operations.1
In the last 10 years, prosthetic valvular endocarditis caused by
Scopulariopsis species has been reported in 3 cases in the literature
(Table 1).2-4 Major emboli, a common presentation of fungal
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Figure 1. Scopulariopsis species isolated from the patient’s
thrombectomy. (Original magniﬁcation 1000; lactophenol cotton
blue stain.)
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endocarditis,1 occurred in 3 of the 4 reported cases, including our
case. Blood cultures did not grow in any of the cases, and the
diagnoses were based on fungal cultures of embolectomy tissue
and prosthetic heart valves. In the cases in which susceptibility
patterns were reported, the organism demonstrated signiﬁcant in
vitro resistance to multiple antifungal agents, corroborating with
other reports noting high-level resistance in clinical isolates of S
brevicaulis.5 Fungal valvular vegetations generally require surgi-
cal intervention for treatment because a long-term cure for fungal
prosthetic endocarditis is unlikely. Subsequent antimicrobial ther-
apy is typically continued for long durations. Although clinical
correlation with in vitro susceptibility data is not fully established
for Scopulariopsis species, the high level of in vitro resistance
demonstrated for Scopulariopsis species to multiple antifungal
agents,5 taken together with several reports of emergency and
progressive infection on broad antifungal therapy, suggests that
successful treatment without surgical debridement might be even
more unlikely for Scopulariopsis species than for other more
treatment-responsive fungi.2-4 The appropriate duration of antifun-
gal therapy after surgical intervention is unclear, although it is
reasonable to continue antifungal agents for several weeks to
months through endothelialization of a prosthetic valve. When
Scopulariopsis species is identiﬁed in a clinical specimen, before
susceptibility results are known, initial empiric use of intravenous
amphotericin B alone or in combination with voriconazole or
itraconazole is reasonable. Additional experience is needed to
optimize antifungal selection in this setting, particularly as relates
to combination antifungal therapy and the role of newer azoles,
such as posaconazole; the echinocandins, such as caspofungin; or
the allylamine terbinaﬁne in synergy. Given the intrinsic resistance
TABLE 1. Four cases of prosthetic valve endocarditis caused by Scopulariopsis species
Case
Presentation-
echocardiogram Timing of presentation Diagnostic study Treatment Outcome
Gentry and
coworkers, 19952
Abdominal pain,
hematuria caused
by large renal
infarct;
pedunculated
vegetation on
echocardiogram
Twelve months after
valvuloplasty with
Duran prosthetic
ring
Valve culture
grew S
brevicaulis
Surgical debridement
and new St Jude’s
mitral prosthesis; 66
days of amphoteri-
cin B and then 90
days of itraconazole
No recurrence at
follow-up
Migrino and
coworkers, 19953
Chest pain;
echocardiogram
demonstrating 3
cm of vegetation
on aortic
prosthesis; then
right leg
claudication with
embolism to
femoral artery
Presented 11
months after
Carpentier-
Edward aortic
valve replacement
for AS
All blood cultures,
including fungal
isolator blood
cultures, were
negative;
cultures of the
embolus and
prosthesis grew
S brevicaulis
Treated with
amphotericin B and
ketoconazole for
synergy; highly
resistant in vitro to
all agents
Progressive infection
leading to death
despite 2 valve
operations and
antifungal therapy
Chen-Scarabelli and
Scarabelli 20034
Fever, purple
ﬁngers;
echocardiogram
with vegetations
on ventricular
side of MV and
linear atrial
densities
Five months after
her third mitral
valve replacement
All blood cultures
were negative;
valve culture
grew
Scopulariopsis
species
Bioprosthetic valve
replacement of
mechanical valve,
treatment with
caspofungin
Alive at hospital
discharge
Current case Cold leg, femoral
arterial septic
emboli;
echocardiogram
with 12 mm of
mitral vegetation
One year (see
above for details)
Blood cultures
and fungal
isolator blood
cultures were
negative;
culture of
embolus grew
S brevicaulis
Treated preoperatively
with amphotericin B
and voriconazole;
bioprosthetic valve
replacement;
treated
postoperatively with
4 weeks of
amphotericin and 11
weeks of
voriconazole
Alive at hospital
discharge;
ultimately expired
from pulmonary
complications
without
recurrence
AS, Aortic stenosis; MV, mitral valve.
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demonstrated by Scopulariopsis species in vitro, early surgical
debridement is the mainstay of therapy for Scopulariopsis species–
induced endocarditis and should be strongly considered when
Scopulariopsis species infection is diagnosed.
References
1. Ellis ME, Al-abdely H, Sandridge A, Greer W, Ventura W. Fungal
endocarditis: evidence in the world literature, 1965-1955. Clin Infect
Dis. 2001;32:50-62.
2. Gentry LO, Nasser MM, Kielhofner M. Scopulariopsis endocarditis asso-
ciated with Duran ring valvuloplasty. Tex Heart Inst J. 1995;22:81-5.
3. Migrino RQ, Hall QS, Longworth DL. Deep tissue infections caused by
Scopulariopsis brevicaulis: report of a case of prosthetic valve endo-
carditis and review. Clin Infect Dis. 1995;21:672-4.
4. Chen-Scarabelli C, Scarabelli TM. Fungal endocarditis due to
Scopulariopsis. Ann Intern Med. 2003;139:w-77.
5. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago M, Monzon
A, Rodriguez-Tudela J. Scopulariopsis brevicaulis, a fungal pathogen
resistant to broad-spectrum antifungal agents. Antimicrob Agents Che-
mother. 2003;47:2339-41.
Erosion of a retroesophageal subclavian artery by an esophageal
prosthesis
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Arterioesophageal ﬁstula is a rare cause of upper diges-tive hemorrhage. It usually presents with a fatal out-come. It may happen in the course of esophageal orthoracic disease, or in the setting of foreign body
ingestion, and involves the thoracic aorta or the subclavian artery.
Arterioesophageal ﬁstula can also occur in the presence of a
retroesophageal subclavian artery (RESCA), also known as arteria
lusoria. It is usually asymptomatic but may cause dysphagia (dys-
phagia lusoria) and may demonstrate symptomatic atherosclerotic
and aneurysmal degeneration. However, spontaneous ﬁstulization
in the esophagus is not described. It has mostly been associated
with prolonged nasogastric tube presence. The present report de-
scribes the ﬁrst case of arterioesophageal ﬁstula with a RESCA
caused by an esophageal prosthesis and discusses treatment based
on a review of the literature.
Clinical Summary
Fourteen months before the actual admission, a 9-year-old girl
with Down syndrome was admitted for caustic ingestion. She
presented with severe ulceration from the middle esophagus down
to the stomach. The acute episode was treated conservatively.
Nonetheless, dysphagia rapidly developed in the patient. Two
months after the accident, an esophagoscopy disclosed active
stenotic esophagitis of the last third of the esophagus. Iterative
pneumatic dilatations were performed, which were discontinued
because of esophageal ﬁssuration and mediastinitis. A 14-mm
Polyﬂex stent was inserted that rapidly migrated into the stomach;
it was extracted and replaced by a 16-mm stent.
In June 2005, the patient was admitted for hematemesis and
melena. Emergency esophagoscopy showed blood oozing around the
prosthesis. The endoscopic procedure was interrupted, and the child
was brought to the catheterization laboratory where the prosthesis
could be mobilized under angiographic control. When the prosthesis
was pushed toward the stomach, a major hemorrhage occurred and a
big aortic branch was identiﬁed as the source of bleeding. First it was
regarded as a major bronchial artery. The prosthesis was pulled back
to enable partial control of the bleeding, and coil embolization was
performed in the so-called bronchial artery. This maneuver did not
control the hemorrhage, and a RESCA was identiﬁed as the source of
bleeding (Figure 1). RESCA embolization was attempted unsuccess-
fully, despite satisfactory angiographic images (Figure 2), and the
patient presented sustained bleeding with hemorrhagic shock and
cardiac arrest. After successful reanimation the patient underwent
emergency surgery consisting of ostial RESCA ligature while the
endoesophageal prosthesis was left in place. An 8-mm polytetraﬂuo-
roethylene (Gore-Tex, Flagstaff, Ariz) prosthetic bypass was con-
structed between the lateral aspect of the ascending aorta and the
axillary artery. The patient had a prolonged intensive care unit stay
(23 days) but fully recovered and was discharged without after-
effects. Although the ﬁrst esophagoscopic control showed embolized
coils visible through the ulcerated esophageal mucosa (Figure E1), the
lesions ﬁnally healed.
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